Replacing CD34+ progenitors of chronic myeloid leukemia in growing conditions is deleterious if autophagy is blocked by the inhibition of the initiating step involving the PI3-kinase class III, Vps34 [24], while sparing normal CD34+ progenitors. Here, CD34 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.